SEC Form 4 · accession 0001453814-15-000006
Medidata Solutions, Inc. · MDSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Eileen Schloss
Other
Period of report
Feb 9, 2015
Accepted (ET)
Feb 11, 2015 · 6:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 9, 2015 | M | 9,946 | $18.76 | A | 55,727 | D | |
| Common Stock | Feb 9, 2015 | M | 2,553 | $37.51 | A | 58,280 | D | |
| Common StockF2 | Feb 9, 2015 | S | 12,499 | $44.4266 | D | 45,781 | D | |
| Common StockF3 | Feb 10, 2015 | F | 934 | $45.38 | D | 44,847 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $18.76 | Feb 9, 2015 | M | 9,946 | D | — | Oct 29, 2022 | Common Stock | 9,946 | 46,301 | D |
| Stock Option (right to buy)F5 | $37.51 | Feb 9, 2015 | M | 2,553 | D | — | Oct 29, 2022 | Common Stock | 2,553 | 34,947 | D |
Explanation of responses
- F1Included are 206 shares which were purchased pursuant to the terms of the Medidata Solutions, Inc. Employee Stock Purchase Plan on December 31, 2014.
- F2Such transaction was executed in multiple trades at prices ranging from $44.40 to $44.57. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3Shares withheld by Medidata to satisfy the tax withholding obligation in connection with the vesting of previously awarded restricted stock.
- F4The options vested as to 25% of the shares on October 29, 2013 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.
- F5The options vested as to 25% of the shares on October 29, 2013 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months